Patent · US Active

Methylpyrrolopyrimidinecarboxamides

US9376442B2 · kind B2 · utility

0Cited by

1References

10Claims

0Family size

Assignee

TAKEDA GMBH · DE

Inventors

Josef Stadlwieser · Konstanz, DE
Beate Schmidt · Allensbach, DE
Heiko Bernsmann · Frankfurt, DE
Torsten Dunkern · Refrath, DE
Ewald Benediktus · Biberach, DE
Andreas Pahl · Ahrensburg, DE
Ragna Hussong · Deißlingen, DE
Olaf Nimz · Konstanz, DE
Matthias Mueller · Konstanz, DE
Martin Viertelhaus · Konstanz, DE

Key dates

Filing date	Nov 19, 2014
Grant date	Jun 28, 2016
Priority date	—
Expiry date	Nov 19, 2034

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The compounds of Formula (I),wherein R1, R2, R21, R22, R23, R24, Y and R3 have the meanings as given in the description, the salts thereof, the stereoisomers of the compounds and the salts thereof are effective inhibitors of the type 5 phosphodiesterase and are useful for treating or preventing idiopathic pulmonary lung fibrosis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.